Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05205161
What this trial is testing

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
AstraZeneca 7
Testing effectiveness (Phase 2)Study completedNCT01262235
What this trial is testing

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Who this might be right for
CancerNeuroendocrine TumorsNET+2 more
Arbutus Biopharma Corporation 68
Testing effectiveness (Phase 2)Study completedNCT01177397
What this trial is testing

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more
Celgene 226
Testing effectiveness (Phase 2)Ended earlyNCT04504708
What this trial is testing

Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies

Who this might be right for
Non-hodgkin LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Hangzhou Zenshine Pharmaceuticals Co., Ltd. 6
Early research (Phase 1)Study completedNCT00779584
What this trial is testing

A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)

Who this might be right for
Hodgkin DiseaseLymphoma, Non-HodgkinNeoplasms
Merck Sharp & Dohme LLC 45
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Early research (Phase 1)Study completedNCT00004241
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Ended earlyNCT00471367
What this trial is testing

Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877

Who this might be right for
LymphomaNHLNon-Hodgkin Lymphoma
AstraZeneca 44
Large-scale testing (Phase 3)Study completedNCT03159897
What this trial is testing

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 500
Large-scale testing (Phase 3)Study completedNCT00003389
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 854
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Early research (Phase 1)Study completedNCT00098891
What this trial is testing

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Not applicableStudy completedNCT03595813
What this trial is testing

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Who this might be right for
Lung Cancer MetastaticLocally Advanced Malignant NeoplasmNon Hodgkin Lymphoma+1 more
Institut Paoli-Calmettes 135
Early research (Phase 1)Study completedNCT00432562
What this trial is testing

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

Who this might be right for
Breast CancerNon-small Cell Lung CancerNon-Hodgkins Lymphoma
Mast Therapeutics, Inc. 31
Early research (Phase 1)Looking for participantsNCT05365659
What this trial is testing

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

Who this might be right for
B-cell Non-Hodgkin LymphomaDiffuse Large B Cell LymphomaFollicular Lymphoma+2 more
Iksuda Therapeutics Ltd. 140
Early research (Phase 1)WithdrawnNCT02548468
What this trial is testing

Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides and Sezary SyndromeStage IIB Mycosis Fungoides and Sezary Syndrome+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Early research (Phase 1)Study completedNCT01032681
What this trial is testing

EMD 521873 in Advanced Solid Tumors, MTD Finding

Who this might be right for
Non-Hodgkin Lymphoma
Merck KGaA, Darmstadt, Germany 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Next Page